Gleison Tibau has now failed two drug tests since USADA took over the UFC’s anti-doping program.
An eight-year UFC veteran, Tibau was provisionally suspended for failing an out-of-competition test conducted on Dec. 4 — about a month after he competed in Sao Paulo Brazil at UFC Fight Night: Belfort vs. Henderson III. Tibau said he tested positive for EPO, but was adamant of his negligence — saying he did not know he’d ingested the PED.
It has now been revealed that Tibau failed a second examination, this time an in-competition test immediately following his UFC Fight Night 77 victory over Abel Trujillo in November.
The UFC wrote in a statement regarding the second failed test:
“The U.S. Anti-Doping Agency (USADA) has notified both Gleason Tibau and UFC of a potential Anti-Doping Policy violation stemming from an in-competition sample collected immediately after his bout in Sao Paulo, Brazil on November 7, 2015. Tibau and UFC were previously notified that he had been provisionally suspended due to a potential Anti-Doping Policy violation stemming from an out-of-competition test.”
Moving forward, USADA will oversee the final decision on Tibau’s punishment.
The anti-doping agency most recently suspended Mirko “Cro Cop” Filipovic two years after the MMA legend tested positive for HGH in the lead-up to his fight with Anthony Hamilton at UFC Fight Night 79.
Tibau has won four of his last five, including wins over Trujillo, Norman Parke, Piotr Hallman and Pat Healy. The 32-year-old Brazilian is also the second-to-last man who owns a victory over UFC lightweight champion Rafael dos Anjos.